A common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.
Thomas Cohn, Chief Strategy Officer, Asembia
Advertisement
Articles by Thomas Cohn, Chief Strategy Officer, Asembia
Advertisement
Latest Updated Articles
Reimagining Specialty Pharmacy: Market Variability Drives New StrategiesPublished: June 13th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Higher-Dose Semaglutide Achieves Significant Weight Reduction in Adults with Obesity
2
Ethical Considerations of Artificial Intelligence Use Abound
3
Boehringer Ingelheim Advances Cardio-Kidney-Metabolic Research Through Integrated Therapeutic Development
4
The Average Health Insurance Premium Now Costs $27k Per Year for a Family
5
